Evaluation of humoral response to Gam-Covid-Vac (Sputnik V) vaccination against COVID-19 in patients on hemodialysis and peritoneal dialysis
- Autores: Shutov E.V1,2, Bolshakov S.A.1, Kotlyarova G.V.1, Emelyanova E.B.1, Sorokoletov S.M.1, Dolidze D.D.1,2
-
Afiliações:
- Botkin Hospital
- Russian Medical Academy of Continuing Professional Education
- Edição: Volume 14, Nº 3 (2022)
- Páginas: 8-14
- Seção: Articles
- URL: https://journals.eco-vector.com/2075-3594/article/view/275444
- DOI: https://doi.org/10.18565/nephrology.2022.3.8-14
- ID: 275444
Citar
Texto integral
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Palavras-chave
Texto integral
Sobre autores
E. Shutov
Botkin Hospital; Russian Medical Academy of Continuing Professional Education
Email: shutov_e_v@mail.ru
MD, PhD, Head of the Interdistrict Nephrology Center; Head of the Department of Nephrology and Dialysis Moscow, Russia
Stepan Bolshakov
Botkin Hospital
Email: bolshakoff123@yandex.ru
therapist, junior researcher of the department of science Moscow, Russia
Galina Kotlyarova
Botkin Hospital
Email: galopa@yandex.ru
Head of the hemodialysis department of the interdistrict nephrological center Moscow, Russia
Elvira Emelyanova
Botkin Hospital
Email: e.allvira@gmail.com
MD, Head of the clinical diagnostic laboratory Moscow, Russia
Sergey Sorokoletov
Botkin Hospital
Email: sorokoletov-sm@mail.ru
MD, PhD, deputy chief physician for therapeutic care Moscow, Russia
David Dolidze
Botkin Hospital; Russian Medical Academy of Continuing Professional Education
Email: ddolidzed@mail.ru
MD, PhD, Head of scientific-clinical department Moscow, Russia
Bibliografia
- Rahman S., Montero M., Rowe K., et al. Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence. Expert. Rev. Clin. Pharmacol. Taylor and Francis Ltd., 2021;14(5):601-21.
- Chams N, Chams S., Badran R., et al. COVID-19: A Multidisciplinary Review. Front. Public Heal. Front. Media S.A., 2020;8:383.
- COVID-19 Map - Johns Hopkins Coronavirus Resource Center [Electronic resource]. URL: https://coronavirus.jhu.edu/map.html(accessed: 22.04.2022).
- Coronavirus Disease (COVID-19) Situation Reports [Electronic resource]. URL: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports (accessed: 22.04.2022).
- Dessie Z.G., Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117patients. BMC. Infect. Dis. 2021;21:1.
- Arentz M., Yim E., Klaff L., et al. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA. Am. Med. Associat. 2020;323(16):1612.
- Malik P., Patel U., Mehta D., et al. Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis. BMJ. Evid. Based Med. 2021;26(3):107-8.
- Kim L., Garg S., OHalloran A., et al. Risk Factors for Intensive Care Unit Admission and In-hospital Mortality Among Hospitalized Adults Identified through the US Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network(COVID-NET). Clin. Infect. Dis. Oxford Academic, 2021;72(9):e206-14.
- Hergens M.P., Bell M., Haglund P., et al. Risk factors for COVID-19-related death, hospitalization and intensive care: a population-wide study of all inhabitants in Stockholm. Eur. J. Epidemiol. 2022;37(2):157-65.
- Vardavas C.I., Nikitara K. COVID-19 and smoking: A systematic review of the evidence. Tob. Induc. Dis.International Society for the Prevention of Tobacco Induced Diseases. 2020;18(March).
- Jdiaa S.S., Masour R., El Alayli A., et al. COVID-19 and chronic kidney disease: an updated overview of reviews. J. Nephrol. Nature Publishing Group. 2022;35(1):69.
- Hsu C.M., Weiner D., Aweh G., et al. COVID-19 Among US Dialysis Patients: Risk Factors and Outcomes From a National Dialysis Provider. Am. J. Kidney Dis. Elsevier. 2021;77(5):748.
- Ziemba R., Campbell K., Yang T., et al. Excess Death Estimates in Patients with End-Stage Renal Disease - United States, February-August 2020. Morb. Mortal. Wkly. Rep. Centers for Disease Control and Prevention. 2021;70(22):825.
- Zubkin M.L., Shilo V., Novikova L., et al. Frequency of SARS-CoV-2 infection in hemodialysis patients. Infect. Dis. News, Opin. Train. Geotar Media Publishing Group. 2021;10(3):23-32.
- Bowe B., Xie Y., Xu E., et al. Kidney Outcomes in Long COVID. J. Am. Soc. Nephrol. 2021;32(11):2851-62.
- Chung E.Y.M., Palmer S., Natale P., et al. Incidence and Outcomes of COVID-19 in People With CKD: A Systematic Review and Meta-analysis. Am. J. Kidney Dis. 2021;78(6):804-15.
- Henry B.M., Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection.Int. Urol. Nephrol. Springer. 2020;52(6):1193-94.
- Diao B., Wang C., Wang R., et al. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection. Nat.Commun. 2021. 121. Nature Publishing Group. 2021;12(1):1-9.
- Cheng Y., Luo R., Wang K., et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. Elsevier. 2020;97(5):829-838.
- Sun J., Zhu A., Li H., et al. Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient. Emerg. Microbes Infect. Taylor and Francis Ltd. 2020;9(1):991-93.
- Lely A.T., Hamming I., van Goor H., et al. Renal ACE2 expression in human kidney disease. J. Pathol. John Wiley & Sons, Ltd. 2004;204(5):587-93.
- Hilbrands L.B., Duivenvoorden R., Vart P., et al. COVID-19-related mortality in kidney transplant anddialysispatients: results of the ERACODA collaboration. Nephrol. Dial. Transplant. Oxford University Press. 2020;35(11):1973.
- Jager K.J., Kramer A., Chesnaye N., et al. Resultsfrom the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe. Kidney Int. Elsevier. 2020;98(6):1540.
- Kang S.H., Kim S., Kim A., et al. Association between Chronic Kidney Disease or Acute Kidney Injury and Clinical Outcomes in COVID-19 Patients. J. Korean Med. Sci. Korean Acad. Med. Sci. 2020;35(50).
- Goh B.L., Shanmuganathan M., Peariasamy K., et al. COVID-19 death and kidney disease in a multiracial Asian country. Nephrol. (Carlton). 2022.
- de Sandes-Freitas T.V., de Andrade L., Moura L., et al.Comparison of 30-day case-fatality rate between dialysis and transplant Covid-19 patients: a propensity score matched cohort study. J. Nephrol. 2022;35(1):131-41.
- Sachdeva M., Uppal N., Hirsch J., et al. COVID-19 in Hospitalized Patients on Chronic Peritoneal Dialysis: A Case Series. Am. J. Nephrol. Karger Publish. 2020;51(8):669-74.
- Jiang H.J., Tang H., Xiong F., et al. COVID-19 in Peritoneal Dialysis Patients. Clin. J. Am. Soc. Nephrol. Am. Soc. Nephrol. 2021;16(1):121-23.
- Salomao Gorayeb-Polacchini F., Cristina Caldas H., Abbud-Filho M., et al. Clinical outcomes of COVID-19 in patients undergoing chronic hemodialysis and peritoneal dialysis. Brazilian J. Nephrol. Soc. Brasil. Nefrol. 2022.
- Eleftheriadis T., Antoniadi G., Liakopoulos V., et al. Disturbances of acquired immunity in hemodialysis patients. Semin. Dial. Semin Dial. 2007;20(5):440-51.
- Descamps-Latscha B. The immune system in end-stage renal disease. Curr. Opin Nephrol. Hypertens. 1993;2(6):883-91.
- Nitta K., Akiba T., Kawashima A., et al. Characterization of TH1/TH2profile in uremic patients. Nephron. 2002;91(3):492-95.
- Kim H.W, Woo Y., Yang H., et al. Primed monocytes: putative culprits of chronic low-grade inflammation and impaired innate immune responses in patients on hemodialysis. Clin. Exp. Nephrol. 2011;15(2):258-263.
- Ando M., Shibuya A., Tsuchiya K., et al. Reduced capacity of mononuclear cells to synthesize cytokines against an inflammatory stimulus in uremic patients. Nephron. Clin. Pract. Nephron Clin. Pract. 2006;104(3).
- Ando M., Shibuya A., Yasuda M., et al. Impairment of innate cellular response to in vitro stimuli in patients on continuous ambulatory peritoneal dialysis. Nephrol. Dial. Transplant. 2005;20(11):2497-503.
- Krueger K.M., Ison M.G., Ghossein C. Practical Guide to Vaccination in All Stages of CKD, Including Patients Treated by Dialysis or Kidney Transplantation. Am. J. Kidney Dis. 2020;75(3):417-25.
- Kato S., Chmielewski M., Honda H., et al. Aspects of Immune Dysfunction in End-stage Renal Disease. Clin. J. Am. Soc. Nephrol. Am. Soc. Nephrol. 2008;3(5):1526.
- Anft M., Blazquez-Navarro A., Paniskaki K., et al. SARS-CoV-2-reactive cellular and humoral immunity in hemodialysis population. Kidney Int. Elsevier. 2021;99(6):1489.
- Shaikh A., Zeldis E., Campbell K., et al. Prolonged SARS-CoV-2 Viral RNA Shedding and IgG Antibody Response to SARS-CoV-2 in Patients on Hemodialysis. Clin. J. Am. Soc. Nephrol. Am. Soc. Nephrol. 2021;16(2):290.
- O’Sullivan E.D., Lees J., Howie K., et al. Prolonged SARS-CoV-2 viral shedding in patients with chronic kidney disease. Nephrology. John Wiley & Sons, Ltd. 2021;26(4):328-32.
- El Shamy O., Vassalotti J., Sharma S., et al. Coronavirus disease 2019 (COVID-19) hospitalized patients with acute kidney injury treated with acute peritoneal dialysis do not have infectious peritoneal dialysis effluent. Kidney Int. Elsevier. 2020;98(3):782.
- Vischini G., DAlonzo S., Grandaliano G., et al. SARS-CoV-2 in the peritoneal waste in a patient treated with peritoneal dialysis. Kidney Int. Elsevier. 2020;98(1):237-38.
- Rincon A., Moreso F., Herradon A., et al. The keys to control a COVID-19 outbreak in a haemodialysis unit. Clin. Kidney J. Oxford Acad. 2020;13(4):542-549.
- Tang H., Tian J., Dong J., et al. Serologic Detection of SARS-CoV-2 Infections in Hemodialysis Centers: A Multicenter Retrospective Study in Wuhan, China. Am. J. Kidney Dis. W.B. Saunders. 2020;76(4):490-9.e1.
- Fiolet T., Kherabi Y., MacDonald C., et al.Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review. Clin. Microbiol. Infect. 2022;28(2):202-21.
- WHO/BS.2020.2403 Establishment of the WHO International Standard and Reference Panel for anti-SARS-CoV-2 antibody [Electronic resource]. URL: https://www.who.int/publications/m/item/WHO-BS-2020.2403 (accessed: 06.06.2022).
- Khoury D.S., Cromer D., Reynaldi A., et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nature Publishing Group. 2021;27(7):1205-11.
- Bergwerk M., Gonen T., Lustig Y., et al. Covid-19 Breakthrough Infections in Vaccinated Health Care Workers. N. Engl. J. Med. Massachusetts Med. Soc. 2021;385(16):1474-84.
- Feng S., Phillips D., White T., et al. Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection. Nat. Med., Nature Publishing Group. 2021;27(11):2032-40.
- Swai J., Gui M., Long M., et al. Humoral and cellular immune response to severe acute respiratory syndrome coronavirus-2 vaccination in haemodialysis and kidney transplant patients. Nephrology. John Wiley & Sons, Ltd. 2022;27(1):7-24.
- Schietzel S., Anderegg M., Limacher A., et al. Humoral and cellular immune responses on SARS-CoV-2 vaccines in patients with anti-CD20 therapies: a systematic review and meta-analysis of 1342 patients. RMD Open. 2022;8(1).
- Van Praet J., Reynders M., De Bacquer D., et al. Predictors and Dynamics of the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccines in Hemodialysis Patients: A Multicenter Observational Study. J. Am. Soc. Nephrol. 2021;32(12):3208-20.
- Ma B.M., Tam A., Chan K., et al. Immunogenicity and Safety of COVID-19 Vaccines in Patients Receiving Renal Replacement Therapy: A Systematic Review and Meta-Analysis. Front. Med. (Lausanne). 2022;9.
- Kolb T., Fischer S., Muller L., et al. Impaired Immune Response to SARS-CoV-2 Vaccination in Dialysis Patients and in Kidney Transplant Recipients. Kidney360. 2021;2(9):1491-98.
- Hsu C.M., Weiner D., Manley H., et al. Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months. CJASN. 2022;17:403-13.
- Hsu C.M., Lacson E., Manley H., et al. Journal Pre-proof Seroresponse to Third Doses of SARS-CoV-2 Vaccine Among Patients Receiving Maintenance Dialysis. Am. J. Kidney Dis. 2022.
- Tung K., Peng Y., Hsu S., et al. Humoral antibody response to the first dose of the ChAdOx1 nCoV-19 vaccine in Asian patients undergoing hemodialysis. Hemodial.Int. 2022.
- Patyna S., Eckes T., Koch B., et al. Impact of Moderna mRNA-1273 Booster Vaccine on Fully Vaccinated High-Risk Chronic Dialysis Patients after Loss of Humoral Response. Vaccines (Basel). 2022;10(4):585.
- Simon B., Rubey H., Treipl A., et al. Haemodialysis patients show a highly diminished antibody response after COVID-19 mRNA vaccination compared with healthy controls. Nephrol. Dial. Transplant. 2021;36(9):1709-16.
- Carr E.J., Wu M., Harvey R., et al. Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients. Lancet. Elsevier B.V. 2021;398(10305):1038-41.
- Yen J.S., Wang I.K., Yen T.H. COVID-19 vaccination and dialysis patients: why the variable response. QJM. 2021;114(7):440-44.
- Windpessl M., Bruchfeld A., Anders H., et al. COVID-19 vaccines and kidney disease. Nat. Rev. Nephrol., Nature Publishing Group. 2021;17(5):291-93.
- Rincon-Arevalo H., Choi M., Stefanski A., et al. Impaired antigen-specific memory B cell and plasma cell responses including lack of specific IgG upon SARS-CoV-2 BNT162b2 vaccination among Kidney Transplant and Dialysis patients. medRxiv. Cold Spring Harbor Laboratory Press. 2021. P. 2021.04.15.21255550.
- Yanay N.B., Freiman S., Shapira M., et al. Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients. Kidney Int. Elsevier. 2021;99(6):1496.
- Grupper A., Sharon N., Finn T., et al. Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis. CJASN. 2021;16:1037-42.
- Carr E.J., Kronbichler A., Graham-Brown M., et al. Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKD. Kidney Int. Reports. Elsevier. 2021;6(9):2292.
- Tada T., Zhou H., Dcosta B., et al. Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies. EBioMedicine. 2022;78.
- Benotmane I., Velay A., Vargas G., et al. Pre-exposure prophylaxis with 300 mg Evusheld elicits limited neutralizing activity against the Omicron variant. Kidney Int., 2022.
- Byazrova M.G., Kulemin S., Astakhova E., et al. Memory B Cells Induced by Sputnik V Vaccination Produce SARS-CoV-2 Neutralizing Antibodies Upon Ex Vivo Restimulation. Front. Immunol. 2022;13.
- Logunov D.Y., Dolzhikova I., Shcheblyakov D., et al. Safety and efficacy of an rAd26 and rAd5 vector-based heterologousprime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet (London, England). 2021;397(10275):671-81.
- Cazzola M., Rogliani P., Mazzeo F., et al. Controversy surrounding the Sputnik V vaccine. Respir. Med. Elsevier. 2021;187:106569.
- Babamahmoodi F, Saeedi M., Alizadeh-Navaei R., et al. Side effects and Immunogenicity following administration of the Sputnik V COVID-19 vaccine in health care workers in Iran. Sci. Rep. Nat. Publish. Group. 2021;11(1).
- Infantino M., Pieri M., Nuccetelli M., et al. The WHO International Standard for COVID-19 serological tests: towards harmonization of anti-spike assays.Int. Immunopharmacol. Elsevier. 2021;100::108095.
- Sui Z., Dai X., Lu Q., et al. Viral dynamics and antibody responses in people with asymptomatic SARS-CoV-2 infection. Signal Transduct. Target. Ther. Nat. Publish. Group. 2021;6(1).
- Chemiluminescence Immunoassay System - CL-6000i - Mindray Global [Electronic resource]. URL: https://www.mindray.com/en/products/laboratory-diagnostics/chemiluminescence-immunoassay/large-test-volume/cl-6000i (accessed: 12.05.2022).
- Anand S., Montez-Rath M., Han J., et al. SARS-CoV-2 Vaccine Antibody Response and Breakthrough Infection in Patients Receiving Dialysis. https://doi.org/10.7326/M21-4176. Am. Coll. Physic. 2021;175(3):371-378.
- Kausz A.T., Gilbertson D.T. Overview of Vaccination in Chronic Kidney Disease. Adv. Chronic Kidney Dis. Elsevier. 2006;13(3):209-14.
- Mathew R., Mason D., Kennedy J.S. Vaccination issues in patients with chronic kidney disease. Expert. Rev. Vaccines. 2014;13(2):285-298.
- Ghadiani M.H., Besharati S., Mousavinasab N., et al. Response rates to HB vaccine in CKD stages 3-4 and hemodialysis patients. J. Res. Med. Sci. Wolters Kluwer - Medknow Publications. 2012;17(6):527.
- Kausz A., Pahari D. The Value of Vaccination in Chronic Kidney Disease. Semin. Dial. John Wiley & Sons. Ltd. 2004;17(1):9-11.
- Johnson D.W., Fleming S.J. The use of vaccines in renal failure. Clin. Pharmacokinet. 1992;22(6):434-46.
- Beaman M., Michael J., Maclennan I., et al. T-cell-independent and T-cell-dependent antibody responses in patients with chronic renal failure. Nephrol. Dial. Transplant. 1989;4(3):216-21.
- Vlassopoulos D. Recombinant hepatitis B vaccination in renal failure patients. Curr. Pharm. Biotechnol. Curr. Pharm. Biotechnol. 2003;4(2):141-151.
- Pneumococcal vaccine in children and young adults with chronic renal disease - PubMed [Electronic resource]. URL: https://pubmed.ncbi.nlm.nih.gov/8671817/(accessed: 14.06.2022).
- Antonen J.A., Hannula P., Pyhala R., et al. Adequate seroresponse to influenza vaccination in dialysis patients. Nephron. 2000;86(1):56-61.
- De Vriese A.S., Reynders M. IgG Antibody Response to SARS-CoV-2 Infection and Viral RNA Persistence in Patients on Maintenance Hemodialysis. Am. J. Kidney Dis. Elsevier. 2020;76(3):440-41.
- Sakhi H., Dahmane D., Attias P., et al. Kinetics of Anti-SARS-CoV-2 IgG Antibodies in Hemodialysis Patients Six Months after Infection. J. Am. Soc. Nephrol. 2021;32(5):1033-36.
- Forbes S., Davari M., Gnanasampanthan S., et al. Persistence of antibody response to SARS-CoV-2 in a cohort of haemodialysis patients with COVID-19. Nephrol. Dial. Transplant. Oxford Acad. 2021;36(7):1292-97.
- Clarke C.L., Prendecki M., Dhutia A., et al. Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection. Kidney Int. Elsevier. 2021;99(6):1470-77.
- De Vriese A.S., Van Praet J., Reynders M., et al. Longevity and correlation with disease severity of the humoral and cellular response to SARS-CoV-2 infection in haemodialysis patients. Clin. Kidney J. Oxford Acad. 2021;14(11):2446-48.